Loading…

Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma

[...]we classified patients into higher ITH (ITH-H) and lower ITH (ITH-L) groups based on the median of ITH score (Supporting Information Methods), validated by the observation that ITH-H tumours spanned multiple epithelial clusters, which were scarce in ITH-L tumours (Figure 1D and Figure S2C,D). F...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and translational medicine 2023-12, Vol.13 (12), p.e1490-n/a
Main Authors: Ge, Jie, Xiao, Xiao, Zhou, Haiyan, Tang, Mimi, Bai, Jing, Zou, Xinchen, Zhang, Chunliu, Huang, Changhao, Feng, Xiang, Liu, Ting, Yi, Xin, Xia, Xuefeng, Liu, Heli, Chen, Zihua
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4110-89bea36c1609f6d2f830ba5a5ed28495456985b5539a8aa96c3d469d87d4dd4c3
container_end_page n/a
container_issue 12
container_start_page e1490
container_title Clinical and translational medicine
container_volume 13
creator Ge, Jie
Xiao, Xiao
Zhou, Haiyan
Tang, Mimi
Bai, Jing
Zou, Xinchen
Zhang, Chunliu
Huang, Changhao
Feng, Xiang
Liu, Ting
Yi, Xin
Xia, Xuefeng
Liu, Heli
Chen, Zihua
description [...]we classified patients into higher ITH (ITH-H) and lower ITH (ITH-L) groups based on the median of ITH score (Supporting Information Methods), validated by the observation that ITH-H tumours spanned multiple epithelial clusters, which were scarce in ITH-L tumours (Figure 1D and Figure S2C,D). Furthermore, ITH correlated with inferior disease-free survival (DFS) in TCGA-STADs, even after adjusting for confounding factors in multivariate COX regression analysis (Figure 1J,K), suggesting ITH as an independent prognostic factor for recurrence.3 Considering Lauren's subtype, intestinal-type epithelial cells exhibited higher levels of CNV (Figure S2I), consistent with previous reports.4 However, no association was observed between Lauren's subtype and ITH degree either in our cohort or in TCGA-STAD data (Figure S2J,K). MYC was previously reported as a potent regulator in tumour-associated macrophages (TAMs).7,8 Consistently, we detected high expression of MYC and its target genes specific to Mφ-SPP1 (Figure 2E,F and Figure S5F). [...]the targets of MYC were mainly upregulated in Mφ-SPP1 compared with the other two cell types (Figure 2G,H). [...]using a novel scoring method based on cellular similarity of transcriptional profiles, we classified GACs into different ITH groups and comprehensively analysed the associated TME heterogeneity.
doi_str_mv 10.1002/ctm2.1490
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0dfa022a8e5944548649e28751528f87</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0dfa022a8e5944548649e28751528f87</doaj_id><sourcerecordid>2896802385</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4110-89bea36c1609f6d2f830ba5a5ed28495456985b5539a8aa96c3d469d87d4dd4c3</originalsourceid><addsrcrecordid>eNp1kc9u1DAQxiMEolXpgRdAkbjAYVvbsRP7iFb8qVTEgXK2Zu3J4lVsL3ay1d54hF77ejwJzm6pEBK-2Jr5-dPM91XVS0ouKCHs0oyeXVCuyJPqlBFCF7Rh7dO_3ifVec4bUo7kSnXseXXSSNJ0gonT6v6rC-sBf_28MzgM9TbF3g2lVCfcIQy5Hicfp1Qfut9xxBTXGNCN-xqMiX4LYT_jUL7OKh4Gtw4QxhqCrZ33U4h52pZmzm6HtXcmRQw7l2LwWDAX6jXkMTlTg8UQDSTjQvTwonrWlwHw_OE-q759eH-z_LS4_vLxavnuemE4pWQh1QqhaQ1tiepby3rZkBUIEGhZ2Vdw0SopVkI0CiSAak1jeaus7Cy3lpvmrLo66toIG71NzkPa6whOHwoxrTWk0ZkBNbE9EMZAolCcCy5brpDJTlDBZC-7ovXmqFV8_DFhHrV3ebYOAsYpayZVKwlrpCjo63_QTfE5lE11Q2RHFekIKdTbI1Vcyzlh_zggJXqOX8_x6zn-wr56UJxWHu0j-SfsAlwegVs34P7_Snp585kdJH8DPyO9lQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3087190700</pqid></control><display><type>article</type><title>Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Ge, Jie ; Xiao, Xiao ; Zhou, Haiyan ; Tang, Mimi ; Bai, Jing ; Zou, Xinchen ; Zhang, Chunliu ; Huang, Changhao ; Feng, Xiang ; Liu, Ting ; Yi, Xin ; Xia, Xuefeng ; Liu, Heli ; Chen, Zihua</creator><creatorcontrib>Ge, Jie ; Xiao, Xiao ; Zhou, Haiyan ; Tang, Mimi ; Bai, Jing ; Zou, Xinchen ; Zhang, Chunliu ; Huang, Changhao ; Feng, Xiang ; Liu, Ting ; Yi, Xin ; Xia, Xuefeng ; Liu, Heli ; Chen, Zihua</creatorcontrib><description>[...]we classified patients into higher ITH (ITH-H) and lower ITH (ITH-L) groups based on the median of ITH score (Supporting Information Methods), validated by the observation that ITH-H tumours spanned multiple epithelial clusters, which were scarce in ITH-L tumours (Figure 1D and Figure S2C,D). Furthermore, ITH correlated with inferior disease-free survival (DFS) in TCGA-STADs, even after adjusting for confounding factors in multivariate COX regression analysis (Figure 1J,K), suggesting ITH as an independent prognostic factor for recurrence.3 Considering Lauren's subtype, intestinal-type epithelial cells exhibited higher levels of CNV (Figure S2I), consistent with previous reports.4 However, no association was observed between Lauren's subtype and ITH degree either in our cohort or in TCGA-STAD data (Figure S2J,K). MYC was previously reported as a potent regulator in tumour-associated macrophages (TAMs).7,8 Consistently, we detected high expression of MYC and its target genes specific to Mφ-SPP1 (Figure 2E,F and Figure S5F). [...]the targets of MYC were mainly upregulated in Mφ-SPP1 compared with the other two cell types (Figure 2G,H). [...]using a novel scoring method based on cellular similarity of transcriptional profiles, we classified GACs into different ITH groups and comprehensively analysed the associated TME heterogeneity.</description><identifier>ISSN: 2001-1326</identifier><identifier>EISSN: 2001-1326</identifier><identifier>DOI: 10.1002/ctm2.1490</identifier><identifier>PMID: 38037525</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Adenocarcinoma - genetics ; Adenocarcinoma - pathology ; Angiogenesis ; Cells ; Conflicts of interest ; Fibroblasts ; Gastric cancer ; Genomics ; Humans ; Hypoxia ; Immunotherapy ; Lymphocytes ; Medical prognosis ; Stomach Neoplasms - genetics ; Stomach Neoplasms - pathology ; Tumor Microenvironment - genetics ; Tumors</subject><ispartof>Clinical and translational medicine, 2023-12, Vol.13 (12), p.e1490-n/a</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4110-89bea36c1609f6d2f830ba5a5ed28495456985b5539a8aa96c3d469d87d4dd4c3</cites><orcidid>0000-0002-8467-7742</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3087190700/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3087190700?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,11541,25731,27901,27902,36989,36990,44566,46027,46451,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38037525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ge, Jie</creatorcontrib><creatorcontrib>Xiao, Xiao</creatorcontrib><creatorcontrib>Zhou, Haiyan</creatorcontrib><creatorcontrib>Tang, Mimi</creatorcontrib><creatorcontrib>Bai, Jing</creatorcontrib><creatorcontrib>Zou, Xinchen</creatorcontrib><creatorcontrib>Zhang, Chunliu</creatorcontrib><creatorcontrib>Huang, Changhao</creatorcontrib><creatorcontrib>Feng, Xiang</creatorcontrib><creatorcontrib>Liu, Ting</creatorcontrib><creatorcontrib>Yi, Xin</creatorcontrib><creatorcontrib>Xia, Xuefeng</creatorcontrib><creatorcontrib>Liu, Heli</creatorcontrib><creatorcontrib>Chen, Zihua</creatorcontrib><title>Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma</title><title>Clinical and translational medicine</title><addtitle>Clin Transl Med</addtitle><description>[...]we classified patients into higher ITH (ITH-H) and lower ITH (ITH-L) groups based on the median of ITH score (Supporting Information Methods), validated by the observation that ITH-H tumours spanned multiple epithelial clusters, which were scarce in ITH-L tumours (Figure 1D and Figure S2C,D). Furthermore, ITH correlated with inferior disease-free survival (DFS) in TCGA-STADs, even after adjusting for confounding factors in multivariate COX regression analysis (Figure 1J,K), suggesting ITH as an independent prognostic factor for recurrence.3 Considering Lauren's subtype, intestinal-type epithelial cells exhibited higher levels of CNV (Figure S2I), consistent with previous reports.4 However, no association was observed between Lauren's subtype and ITH degree either in our cohort or in TCGA-STAD data (Figure S2J,K). MYC was previously reported as a potent regulator in tumour-associated macrophages (TAMs).7,8 Consistently, we detected high expression of MYC and its target genes specific to Mφ-SPP1 (Figure 2E,F and Figure S5F). [...]the targets of MYC were mainly upregulated in Mφ-SPP1 compared with the other two cell types (Figure 2G,H). [...]using a novel scoring method based on cellular similarity of transcriptional profiles, we classified GACs into different ITH groups and comprehensively analysed the associated TME heterogeneity.</description><subject>Adenocarcinoma - genetics</subject><subject>Adenocarcinoma - pathology</subject><subject>Angiogenesis</subject><subject>Cells</subject><subject>Conflicts of interest</subject><subject>Fibroblasts</subject><subject>Gastric cancer</subject><subject>Genomics</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Immunotherapy</subject><subject>Lymphocytes</subject><subject>Medical prognosis</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - pathology</subject><subject>Tumor Microenvironment - genetics</subject><subject>Tumors</subject><issn>2001-1326</issn><issn>2001-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kc9u1DAQxiMEolXpgRdAkbjAYVvbsRP7iFb8qVTEgXK2Zu3J4lVsL3ay1d54hF77ejwJzm6pEBK-2Jr5-dPM91XVS0ouKCHs0oyeXVCuyJPqlBFCF7Rh7dO_3ifVec4bUo7kSnXseXXSSNJ0gonT6v6rC-sBf_28MzgM9TbF3g2lVCfcIQy5Hicfp1Qfut9xxBTXGNCN-xqMiX4LYT_jUL7OKh4Gtw4QxhqCrZ33U4h52pZmzm6HtXcmRQw7l2LwWDAX6jXkMTlTg8UQDSTjQvTwonrWlwHw_OE-q759eH-z_LS4_vLxavnuemE4pWQh1QqhaQ1tiepby3rZkBUIEGhZ2Vdw0SopVkI0CiSAak1jeaus7Cy3lpvmrLo66toIG71NzkPa6whOHwoxrTWk0ZkBNbE9EMZAolCcCy5brpDJTlDBZC-7ovXmqFV8_DFhHrV3ebYOAsYpayZVKwlrpCjo63_QTfE5lE11Q2RHFekIKdTbI1Vcyzlh_zggJXqOX8_x6zn-wr56UJxWHu0j-SfsAlwegVs34P7_Snp585kdJH8DPyO9lQ</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Ge, Jie</creator><creator>Xiao, Xiao</creator><creator>Zhou, Haiyan</creator><creator>Tang, Mimi</creator><creator>Bai, Jing</creator><creator>Zou, Xinchen</creator><creator>Zhang, Chunliu</creator><creator>Huang, Changhao</creator><creator>Feng, Xiang</creator><creator>Liu, Ting</creator><creator>Yi, Xin</creator><creator>Xia, Xuefeng</creator><creator>Liu, Heli</creator><creator>Chen, Zihua</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8467-7742</orcidid></search><sort><creationdate>202312</creationdate><title>Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma</title><author>Ge, Jie ; Xiao, Xiao ; Zhou, Haiyan ; Tang, Mimi ; Bai, Jing ; Zou, Xinchen ; Zhang, Chunliu ; Huang, Changhao ; Feng, Xiang ; Liu, Ting ; Yi, Xin ; Xia, Xuefeng ; Liu, Heli ; Chen, Zihua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4110-89bea36c1609f6d2f830ba5a5ed28495456985b5539a8aa96c3d469d87d4dd4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adenocarcinoma - pathology</topic><topic>Angiogenesis</topic><topic>Cells</topic><topic>Conflicts of interest</topic><topic>Fibroblasts</topic><topic>Gastric cancer</topic><topic>Genomics</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Immunotherapy</topic><topic>Lymphocytes</topic><topic>Medical prognosis</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - pathology</topic><topic>Tumor Microenvironment - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ge, Jie</creatorcontrib><creatorcontrib>Xiao, Xiao</creatorcontrib><creatorcontrib>Zhou, Haiyan</creatorcontrib><creatorcontrib>Tang, Mimi</creatorcontrib><creatorcontrib>Bai, Jing</creatorcontrib><creatorcontrib>Zou, Xinchen</creatorcontrib><creatorcontrib>Zhang, Chunliu</creatorcontrib><creatorcontrib>Huang, Changhao</creatorcontrib><creatorcontrib>Feng, Xiang</creatorcontrib><creatorcontrib>Liu, Ting</creatorcontrib><creatorcontrib>Yi, Xin</creatorcontrib><creatorcontrib>Xia, Xuefeng</creatorcontrib><creatorcontrib>Liu, Heli</creatorcontrib><creatorcontrib>Chen, Zihua</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical and translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ge, Jie</au><au>Xiao, Xiao</au><au>Zhou, Haiyan</au><au>Tang, Mimi</au><au>Bai, Jing</au><au>Zou, Xinchen</au><au>Zhang, Chunliu</au><au>Huang, Changhao</au><au>Feng, Xiang</au><au>Liu, Ting</au><au>Yi, Xin</au><au>Xia, Xuefeng</au><au>Liu, Heli</au><au>Chen, Zihua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma</atitle><jtitle>Clinical and translational medicine</jtitle><addtitle>Clin Transl Med</addtitle><date>2023-12</date><risdate>2023</risdate><volume>13</volume><issue>12</issue><spage>e1490</spage><epage>n/a</epage><pages>e1490-n/a</pages><issn>2001-1326</issn><eissn>2001-1326</eissn><abstract>[...]we classified patients into higher ITH (ITH-H) and lower ITH (ITH-L) groups based on the median of ITH score (Supporting Information Methods), validated by the observation that ITH-H tumours spanned multiple epithelial clusters, which were scarce in ITH-L tumours (Figure 1D and Figure S2C,D). Furthermore, ITH correlated with inferior disease-free survival (DFS) in TCGA-STADs, even after adjusting for confounding factors in multivariate COX regression analysis (Figure 1J,K), suggesting ITH as an independent prognostic factor for recurrence.3 Considering Lauren's subtype, intestinal-type epithelial cells exhibited higher levels of CNV (Figure S2I), consistent with previous reports.4 However, no association was observed between Lauren's subtype and ITH degree either in our cohort or in TCGA-STAD data (Figure S2J,K). MYC was previously reported as a potent regulator in tumour-associated macrophages (TAMs).7,8 Consistently, we detected high expression of MYC and its target genes specific to Mφ-SPP1 (Figure 2E,F and Figure S5F). [...]the targets of MYC were mainly upregulated in Mφ-SPP1 compared with the other two cell types (Figure 2G,H). [...]using a novel scoring method based on cellular similarity of transcriptional profiles, we classified GACs into different ITH groups and comprehensively analysed the associated TME heterogeneity.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38037525</pmid><doi>10.1002/ctm2.1490</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8467-7742</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2001-1326
ispartof Clinical and translational medicine, 2023-12, Vol.13 (12), p.e1490-n/a
issn 2001-1326
2001-1326
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0dfa022a8e5944548649e28751528f87
source Wiley-Blackwell Open Access Collection; Publicly Available Content Database; PubMed Central
subjects Adenocarcinoma - genetics
Adenocarcinoma - pathology
Angiogenesis
Cells
Conflicts of interest
Fibroblasts
Gastric cancer
Genomics
Humans
Hypoxia
Immunotherapy
Lymphocytes
Medical prognosis
Stomach Neoplasms - genetics
Stomach Neoplasms - pathology
Tumor Microenvironment - genetics
Tumors
title Single‐cell profiling reveals tumour cell heterogeneity accompanying a pre‐malignant and immunosuppressive microenvironment in gastric adenocarcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T03%3A43%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single%E2%80%90cell%20profiling%20reveals%20tumour%20cell%20heterogeneity%20accompanying%20a%20pre%E2%80%90malignant%20and%20immunosuppressive%20microenvironment%20in%20gastric%20adenocarcinoma&rft.jtitle=Clinical%20and%20translational%20medicine&rft.au=Ge,%20Jie&rft.date=2023-12&rft.volume=13&rft.issue=12&rft.spage=e1490&rft.epage=n/a&rft.pages=e1490-n/a&rft.issn=2001-1326&rft.eissn=2001-1326&rft_id=info:doi/10.1002/ctm2.1490&rft_dat=%3Cproquest_doaj_%3E2896802385%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4110-89bea36c1609f6d2f830ba5a5ed28495456985b5539a8aa96c3d469d87d4dd4c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3087190700&rft_id=info:pmid/38037525&rfr_iscdi=true